<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03462472</url>
  </required_header>
  <id_info>
    <org_study_id>11112015-2</org_study_id>
    <nct_id>NCT03462472</nct_id>
  </id_info>
  <brief_title>Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD</brief_title>
  <official_title>The Acute Effects of Leg Heating and Transcutaneous Electrical Nerve Stimulation on Leg Blood Flow and Functional Capacity in Those With Peripheral Arterial Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Salisbury University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Salisbury University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral arterial disease (PAD) is characterized by poor circulation in the lower
      extremities that often provokes claudication (leg pain, numbness, and heaviness) with
      physical exertion. The aim of this research protocol is to determine the effect of two
      non-invasive treatment modalities on leg blood flow and exercise capacity in those with PAD.
      Specifically, we are measuring popliteal artery blood flow (Doppler ultrasound), toe oxygen
      saturation, ankle-brachial index (ABI), and 6-minute walking distance (6MWD) in men and women
      who have intermittent claudication (Fontaine Stage II; Rutherford Category 1-2) in response
      to 15 or 45 minutes of lower limb heating and transcutaneous electrical nerve stimulation
      (TENS).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance walked during six-minute walk test</measure>
    <time_frame>35 minutes post-intervention/control</time_frame>
    <description>Distance walked during a self-paced six-minute walk</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Popliteal artery blood flow</measure>
    <time_frame>Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control</time_frame>
    <description>Unilateral popliteal blood flow measured via Doppler ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time/distance to claudication during six-minute walk</measure>
    <time_frame>35 minutes following each intervention and control period</time_frame>
    <description>Subjects give subjective ratings of claudication onset, if applicable, during six-minute walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ankle brachial index (ABI)</measure>
    <time_frame>Pre-intervention baseline and 20 minutes post-intervention/control</time_frame>
    <description>Systolic blood pressures (SBP) are measured in the brachial arteries of both arms and in the posterior tibial and dorsalis pedis arteries of both ankles using a hand-held Doppler ultrasound probe and a sphygmomanometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toe oxygen saturation</measure>
    <time_frame>Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control</time_frame>
    <description>A pulse oximeter is used to measure toe oxygen saturation in the big toe of each of the subject's feet</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>15 minute lower leg heating</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>45 minute lower leg heating</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>15 minute lower leg TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>45 minute lower leg TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lower leg heating</intervention_name>
    <description>Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius</description>
    <arm_group_label>15 minute lower leg heating</arm_group_label>
    <arm_group_label>45 minute lower leg heating</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lower leg transcutaneous electrical nerve stimulation (TENS)</intervention_name>
    <description>Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 Âµs pulse duration, sufficient to evoke skeletal muscle contraction</description>
    <arm_group_label>15 minute lower leg TENS</arm_group_label>
    <arm_group_label>45 minute lower leg TENS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intermittent claudication (Fontaine Stage II)

          -  Resting ankle-brachial index (ABI) &lt; 0.90

          -  Ability to walk &gt; 60 meters in six minutes

        Exclusion Criteria:

          -  Body mass index (BMI) &gt; 35 kg/m2

          -  Severe exercise limitations (more than PAD) due to co-morbidity

          -  Taking illegal/recreational drugs

          -  Uncontrolled hypertension (&gt;180/100 mmHg)

          -  Severe peripheral neuropathy

          -  Foot ulcers

          -  Gangrene

          -  Pregnant or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas K. Pellinger, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Salisbury University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tom Pellinger, Ph.D.</last_name>
    <phone>410-677-0144</phone>
    <email>tkpellinger@salisbury.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Salisbury University</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Pellinger, Ph.D.</last_name>
      <phone>410-677-0144</phone>
      <email>tkpellinger@salisbury.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2018</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

